藥物流行病學
Pharmacoepidemiology
| 節 | 週二 |
|---|---|
5 13:20–14:10 | 藥物流行病學 YL405（陽明） 2 節連堂 |
6 14:20–15:10 |
* 根據陽明交大上課時間表所列
透過課堂講授、文獻報告、專家演講讓同學們了解藥物流行病學常見研究設計與初級資料收集基本原理、重要方法學議題、在臺灣藥政領域的應用。
.
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | 09/02 Course overview and introduction to pharmacoepidemiology 時數：[2025-09-02]東雅惠(2.00) |
| 第 2 週 | 09/09 Studies of drug utilization and prescribing patterns 時數：[2025-09-09]許家禎(2.00) |
| 第 3 週 | 09/16 Cohort studies and corresponding methodological considerations 時數：[2025-09-16]東雅惠(2.00) |
| 第 4 週 | 09/23 Studies of medication adherence 時數：[2025-09-23]周千瀅(2.00) |
| 第 5 週 | 09/30 Case studies* 時數：[2025-09-30]東雅惠(2.00) |
| 第 6 週 | 10/07 Case-control studies and corresponding methodological considerations 時數：[2025-10-07]王孟廷(2.00) |
| 第 7 週 | 10/14 Case studies* 時數：[2025-10-14]王孟廷(2.00) |
| 第 8 週 | 10/21 Case-only studies and corresponding methodological considerations (Note) 時數：[2025-10-21]王孟廷(2.00) |
| 第 9 週 | 10/28 Case studies* (Note) 時數：[2025-10-28]王孟廷(2.00) |
| 第 10 週 | 11/04 Comorbidity measures and control for confounding 時數：[2025-11-04]東雅惠(2.00) |
| 第 11 週 | 11/11 Special topic: Application of primary data collection in healthcare services research 時數：[2025-11-11]黃彥銘(2.00) |
| 第 12 週 | 11/18 Randomized controlled trials 時數：[2025-11-18]東雅惠(2.00) |
| 第 13 週 | 11/25 Special topic: Spontaneous pharmacovigilance reporting system & postmarketing drug safety surveillance 時數：[2025-11-25]黃薇伊(2.00) |
| 第 14 週 | 12/02 Special topic: Health technology assessment 時數：[2025-12-02]高暉涵(2.00) |
| 第 15 週 | 12/9 Group discussion: Target trial emulation 時數：[2025-12-09]東雅惠(2.00) |
| 第 16 週 | 12/16 Open book examination 時數：[2025-12-16]東雅惠(2.00) |
1. Pharmacoepidemiology. Brian L. Strom, Stephen E. Kimmel, Sean Hennessy. New York: Wiley-Blackwell. 6th ed., 2019. 2. International Society for Pharmacoepidemiology. Guidelines for Good Pharmacoepidemiology Practices (GPP). https://www.pharmacoepi.org/resources/policies/guidelines-08027 3. European Network of Centers for Pharmacoepidemiology and Pharmacovigilance. Guide on Methodological Standards in Pharmacoepidemiology. http://encepp.eu/standards_and_guidances/methodologicalGuide.shtml 4. US Food and Drug Administration. Framework for FDA’s real-world evidence program. https://www.fda.gov/media/120060/download 5. Guidance for Industry and FDA Staff -- Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data. https://www.fda.gov/media/79922/download 6. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) Module VIII – Post-authorisation safety studies (Rev 3) http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129137.pdf 7. 授課教師指定參考教材
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料